المؤلفون: Nico M Wulffraat, Joost F Swart, Sebastiaan J. Vastert

المصدر: Expert Opinion on Orphan Drugs. 2:181-188

مصطلحات موضوعية: Anakinra, business.industry, medicine.drug_class, Health Policy, Arthritis, medicine.disease, Receptor antagonist, Blockade, Orphan drug, Rheumatoid arthritis, Macrophage activation syndrome, Immunology, Medicine, Pharmacology (medical), business, Periodic fever syndrome, Pharmacology, Toxicology and Pharmaceutics (miscellaneous), medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::c9448edefb15b84ee897017a82b8c871Test
https://doi.org/10.1517/21678707.2014.872027Test

المؤلفون: Michelle Möhlmann, Daantje Barug, Joost F. Swart, Nico M Wulffraat

المصدر: Expert Opinion on Biological Therapy. 10:1743-1752

مصطلحات موضوعية: medicine.medical_specialty, Cost-Benefit Analysis, Clinical Biochemistry, Arthritis, Off-label use, Risk Assessment, Drug Costs, Internal medicine, Drug Discovery, Product Surveillance, Postmarketing, Humans, Medicine, Adverse effect, Drug Labeling, Pharmacology, Anakinra, business.industry, Off-Label Use, medicine.disease, Rash, Arthritis, Juvenile, Rheumatology, Interleukin 1 Receptor Antagonist Protein, Treatment Outcome, Interleukin 1 receptor antagonist, Antirheumatic Agents, Immunology, Methotrexate, medicine.symptom, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51ff59fb3a57203276fb3db9a6f231f8Test
https://doi.org/10.1517/14712598.2010.532785Test